ORA files Form 144: planned resale of equity instruments

ORA: Form 144 notice reporting intended sale of securities.

Rhea-AI Filing Summary

ORA: Form 144 notice reporting intended sale of securities. The filing lists securities to be sold on 05/13/2026 on the NYSE, including Common stock, Performance and Restricted Stock (date listed 05/12/2024), and Stock Appreciation Rights (date listed 05/13/2026). The filing records an amount $1,235,387.58 and numeric entries of 9429, 8930, and 499 associated with listed securities.

Insights

Corporate Compliance Officer

Notice documents planned resale of multiple equity instruments on the NYSE.

The excerpt lists Common stock, Performance and Restricted Stock, and Stock Appreciation Rights with dates 05/12/2024 and 05/13/2026. It records $1,235,387.58 and several numeric identifiers.

Cash‑flow treatment and precise share counts tied to those numeric entries are not detailed in the excerpt; subsequent filings or transaction confirmations will show execution specifics and purchaser/underwriter roles.

Key Figures

Filing date listed: 05/13/2026 Recorded amount: $1,235,387.58 Numeric identifier: 9429 +2 more

5 metrics

Filing date listed 05/13/2026 date associated with securities to be sold

Recorded amount $1,235,387.58 amount shown in the excerpt

Numeric identifier 9429 listed alongside Common security entry

Numeric identifier 8930 listed alongside Performance and Restricted Stock entry

Numeric identifier 499 listed alongside Stock Appreciation Rights entry

Key Terms

Stock Appreciation Rights, Performance and Restricted Stock, ISSUER

3 terms

Stock Appreciation Rights financial

"Common | 05/13/2026 | Stock Appreciation Rights | ISSUER"

Stock appreciation rights (SARs) are a form of employee compensation that give the holder the right to receive the increase in a company's stock price over a set baseline, paid in cash or shares, without having to buy the stock. For investors, SARs matter because they can create future cash outflows or share dilution and signal how a company rewards and motivates executives — similar to giving a bonus tied directly to how well the company’s stock performs.

Performance and Restricted Stock financial

"Common | 05/12/2024 | Performance and Restricted Stock | ISSUER"

ISSUER regulatory

"Performance and Restricted Stock | ISSUER"

FAQ

What does ORA's Form 144 report?

It reports intended sales of securities including Common stock, Performance and Restricted Stock, and Stock Appreciation Rights on 05/13/2026. The filing lists numeric entries and an amount of $1,235,387.58.

Which securities types are listed in the Form 144 for ORA?

The filing lists Common stock, Performance and Restricted Stock (date 05/12/2024), and Stock Appreciation Rights (date 05/13/2026). It identifies these as issued by the ISSUER.

Does the Form 144 show where the sales will occur?

Yes; the excerpt indicates the sales are listed for the NYSE. The document does not provide execution details such as broker-dealers or sale methods within the provided excerpt.

How much value is recorded in this excerpt of ORA's Form 144?

The excerpt shows an amount of $1,235,387.58 tied to the filing. The context for that amount (proceeds, fair market value, or filing fee basis) is not specified in the excerpt.

Are exact share counts provided in the excerpt?

The excerpt includes numeric entries (9429, 8930, 499) that appear alongside listed securities. The filing does not label these explicitly as total outstanding or specific share counts in the provided text.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/13/2026 - 04:04 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001810578
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ORMAT TECHNOLOGIES, INC.
SEC File Number	001-32347
Address of Issuer	6884 Sierra Center Pkwy Reno NEVADA 89511-2210
Phone	(775) 356-9029
Name of Person for Whose Account the Securities are To Be Sold	OFER BENYOSEF
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	9429	1235387.58	61451752	05/13/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/12/2024	Performance and Restricted Stock	ISSUER			8930	05/12/2024	Not Applicable
Common	05/13/2026	Stock Appreciation Rights	ISSUER			499	05/13/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock and Performance Shares during the period of 05/12/2024 through 03/21/2026.
Date of Notice	05/13/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Ofer Benyosef
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)